Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thyroid cancer
Maria E. Cabanillas, David G. McFadden, Cosimo Durante
The Lancet (2016) Vol. 388, Iss. 10061, pp. 2783-2795
Open Access | Times Cited: 1236

Showing 1-25 of 1236 citing articles:

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Maria E. Cabanillas, Mabel Ryder, Camilo Jiménez
Endocrine Reviews (2019) Vol. 40, Iss. 6, pp. 1573-1604
Open Access | Times Cited: 268
Global Burden of Thyroid Cancer From 1990 to 2017
Yujiao Deng, Hongtao Li, Meng Wang, et al.
JAMA Network Open (2020) Vol. 3, Iss. 6, pp. e208759-e208759
Open Access | Times Cited: 262
Thyroid surgery for differentiated thyroid cancer — recent advances and future directions
Tracy Wang, Julie Ann Sosa
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 11, pp. 670-683
Closed Access | Times Cited: 207
Role of Emerging Environmental Risk Factors in Thyroid Cancer: A Brief Review
Maria Fiore, Gea Oliveri Conti, Rosario Caltabiano, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 7, pp. 1185-1185
Open Access | Times Cited: 155
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Cancer in Africa: The Untold Story
Yosr Hamdi, Ines Abdeljaoued-Tej, Afzal Ali Zatchi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 125
METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8-mediated neutrophil infiltration
Jing He, Mingxia Zhou, Jie Yin, et al.
Molecular Therapy (2021) Vol. 29, Iss. 5, pp. 1821-1837
Open Access | Times Cited: 123
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner
Jiapeng Huang, Wei Sun, Zhihong Wang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 123
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Review of Deep Learning Approaches for Thyroid Cancer Diagnosis
Shokofeh Anari, N. Sarshar, Negin Mahjoori, et al.
Mathematical Problems in Engineering (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 84
Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review
Roger Chou, Tracy Dana, Megan R. Haymart, et al.
Thyroid (2022) Vol. 32, Iss. 4, pp. 351-367
Open Access | Times Cited: 76
KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway
Wei Zhang, Xianhui Ruan, Yaoshuang Li, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1500-1517
Open Access | Times Cited: 72
Single‐cell RNA‐sequencing and spatial transcriptomic analysis reveal a distinct population of APOE− cells yielding pathological lymph node metastasis in papillary thyroid cancer
Guohui Xiao, Rongli Xie, Jianhua Gu, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis
Yao Yao, Xinyuan Chen, Hong Yang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 120
Molecular targets of tyrosine kinase inhibitors in thyroid cancer
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, et al.
Seminars in Cancer Biology (2020) Vol. 79, pp. 180-196
Closed Access | Times Cited: 113
The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.
Bo Lin, Haiqing Ma, Maoguang Ma, et al.
PubMed (2019) Vol. 11, Iss. 9, pp. 5888-5896
Closed Access | Times Cited: 110
Multikinase Inhibitor Treatment in Thyroid Cancer
Ole Vincent Ancker, Marcus Krüger, Markus Wehland, et al.
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 10-10
Open Access | Times Cited: 109
Follow-up of differentiated thyroid cancer – what should (and what should not) be done
Livia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 9, pp. 538-551
Closed Access | Times Cited: 104
PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports
Maike J.M. Uijen, Yvonne H. W. Derks, Robin Merkx, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 13, pp. 4350-4368
Open Access | Times Cited: 103
Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer
Yongkun Sun, Feng Du, Ming Gao, et al.
Thyroid (2018) Vol. 28, Iss. 11, pp. 1455-1461
Closed Access | Times Cited: 100
<p>Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment</p>
Monica Capozzi, Chiara De Divitiis, Alessandro Ottaiano, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 3847-3860
Open Access | Times Cited: 98
MicroRNAs as Biomarkers in Thyroid Carcinoma
Marilena Celano, Francesca Rosignolo, Valentina Maggisano, et al.
International Journal of Genomics (2017) Vol. 2017, pp. 1-11
Open Access | Times Cited: 95
Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation
Naoki Oishi, Tetsuo Kondo, Aya Ebina, et al.
Modern Pathology (2017) Vol. 30, Iss. 11, pp. 1527-1537
Open Access | Times Cited: 89
A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed
Shuncong Wang, Yewei Liu, Yuanbo Feng, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1782-1782
Open Access | Times Cited: 89
The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis
Detao Yin, Huanan He, Kun Yu, et al.
International Journal of Surgery (2018) Vol. 57, pp. 66-75
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top